Simulate the Market and Leverage Opportunities – AXIA worked with multiple clients to map, model and simulate the market space for a brand, franchise, or portfolio. Based on the scenario generation, these initiatives have resulted in brand plans with specific investment allocations.

Size the Market Opportunity – AXIA assisted a client in defining two co-morbid conditions likely to be expanded opportunities based on positive clinical trial findings. For this inquiry, AXIA sized the market based on prevalence, diagnosis and treatment rates in eight different countries around the world. This helped the company invest more strategically to maximize long term returns.

Develop Market Strategy – The client for this assignment was considering entering an established therapeutic area, but one new to them. AXIA identified several strategic options for the client, backed by a comprehensive market competitive analysis.

Anticipate Market Evolution – The client was developing a new product that is likely to define a new therapeutic area, currently a subset of an existing broader one. Using diverse information sets, augmented with thought leader, community prescriber and patient learning, AXIA helped direct the company’s plans for success in this emerging therapeutic area.

Determine Viability of a Global Strategy – AXIA worked with a client to explore unmet needs and opportunity for a novel therapy in five countries. Based on an analysis of attitudes, habits and practices, as well as patient segments, AXIA determined the feasibility of a global brand strategy for the new agent.

Develop Positioning Platform and Key Messages – The client had a new product with a recently accelerated launch plan. With no time for the ideal systematic series of positioning, message development and execution testing research, they called upon AXIA to generate the customer insights and collaborate with the brand team and agency to move quickly and insightfully from concept to finished sales aid.

Transform Consumer Insight into Message Strategy – AXIA’s client had identified several consumer segments for its already popular prescription product, but wanted to maximize its market penetration by beginning to tailor messages to the needs of specific segments. AXIA isolated both rational and emotional consumer triggers to product acceptance and matched product messages to segments.

Secure Competitive Advantage – AXIA’s client was preparing to enter a category up to this point defined by a single, innovative agent. Competition would be fierce. The client’s multidisciplinary strategy team recognized the need for a “war games” facilitated session filled with role play, brainstorming, and prioritization of an immediate action plan. AXIA developed materials, facilitated a full day of small and large group sessions, and supported the client’s leadership in taking ownership of next steps.

Identify Novel Clinical Trial Endpoints – Results of early clinical trials demonstrated a number of potential benefits for a new compound in development. AXIA assisted the client in assessing and prioritizing the value of these benefits in terms of clinical need and differentiation of the product to help guide the focus of later-stage clinical trials.

Prioritize Early Commercial Opportunities – The client was evaluating four compounds in early development within the same therapeutic area. AXIA assisted the client by determining the potential of the compounds to fill unmet needs in the therapeutic area by identifying and speaking with key opinion leaders and community-based physicians. In addition, AXIA sized the market opportunity for each of these compounds by estimating both patient volume and forecasted dollars to further assist in prioritizing the value to the client’s portfolio.

New Technology Feasibility – The client has a product in development that offers a unique mechanism of action, allowing it to be used in a novel way compared with other drugs in the same therapeutic class. The client wanted to gauge both the level of physician understanding and interest in the scientific details, including mechanism of action, pharmacokinetic/pharmacodynamic data and in vitro data, to develop different potential scenarios of use

Evaluate In-licensing Opportunity – The client was in the process of evaluating an in-licensing opportunity in the hospital arena. AXIA assisted in assessing the decision making dynamics around formulary and pharmacy issues and the potential for equipment and labor cost savings with use of the new agent. AXIA evaluated pricing scenarios and estimated potential value of the new product as input to the business development decision.

Assess Enterprise Growth Potential – AXIA’s client was an ex-US manufacturing company needing to evaluate the potential for growth in the US market. AXIA identified a mix of appropriate customers, interviewed executives, and provided recommendations to the client on the current dynamics, optimal sectors with growth potential and next steps for the client to achieve their goals.

Achieve Operating Team Effectiveness – The client for this assignment had assembled a multi-functional team to focus on a new technological arena. AXIA worked with the team to guide management in the development of their business purpose and focus their operating strategy.

Achieve Leadership Excellence – The client, a major pharmaceutical firm, wanted to improve its operating culture in terms of leadership development. AXIA helped to assess the current situation, articulate the future vision of leadership in the organization and recommend specific action steps for different levels of management.